ShareValue scores for 2506.HK: Valuation 41, Quality 39, Growth 54, Health 41.

2506.HK
HKEX

Xunfei Healthcare Tech Co Ltd

HK$67.80(-1.67%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

5% to 16%
Valuation
41
Fair Value
Price vs Value
Quality
39
Weak
Business Strength
Growth
54
Moderate
Revenue & Earnings
Health
41
Moderate
Financial Stability
Momentum
37
Bearish
Price Trend

Company Details

About

Xunfei Healthcare Technology Co., Ltd. provides healthcare AI solutions in the People's Republic of China. The company offers primary solutions, including a general practice clinical decision support system (CDSS) and chronic disease management, which enables identification of key populations, one-click chronic disease screening and risk stratification, dynamic health monitoring, smart task reminders, and decision support during service delivery. It also offers smart hospital solutions, including smart service, smart healthcare, smart medical treatment combination, as well as the iFlytek Xiaoyi APP, an AI health assistant. In addition, the company provides regional public health solutions and medical insurance administrative solutions. Further, the company provides the Xunfei Xiaoyi APP, an AI-driven post-discharge patient management system, and the Cloud Medical Imaging Platform, which offers remote consultation services; and digital imaging services. Additionally, it offers intelligent healthcare solutions, including a general practitioner assistant, grass-roots integrated intelligent information platform, family physician assistant, AI chronic disease management system, and a smart surveillance and early warning platform for infectious diseases. The company's intelligent hardware offerings include smart hearing aids and a smart sphygmomanometer. The company was formerly known as Anhui Xunfei Medical Co., Ltd. and changed its name to Xunfei Healthcare Technology Co., Ltd. in February 2023. The company was founded in 2016 and is headquartered in Hefei, the People's Republic of China. Address: FLYTEK AI Research and Development Production Base (Phase I), Hefei, China

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026